SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038956
Filing Date
2023-11-14
Accepted
2023-11-14 16:26:14
Documents
86
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jan-20230930.htm   iXBRL 10-Q 1225174
2 EX-31.1 jan-20230930xexx311.htm EX-31.1 9627
3 EX-31.2 jan-20230930xexx312.htm EX-31.2 9651
4 EX-32.1 jan-20230930xexx321.htm EX-32.1 3668
5 EX-32.2 jan-20230930xexx322.htm EX-32.2 3667
  Complete submission text file 0001628280-23-038956.txt   8071852

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20230930.xsd EX-101.SCH 72978
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jan-20230930_cal.xml EX-101.CAL 125958
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jan-20230930_def.xml EX-101.DEF 399663
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20230930_lab.xml EX-101.LAB 776289
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20230930_pre.xml EX-101.PRE 578874
80 EXTRACTED XBRL INSTANCE DOCUMENT jan-20230930_htm.xml XML 1063637
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19621 | Film No.: 231406844
SIC: 2834 Pharmaceutical Preparations